1 |
Stutzman DL. Long-term use of antidepressants, mood stabilizers, and antipsychotics in pediatric patients with a focus on appropriate deprescribing. Ment Health Clin 2021;11:320-33. [PMID: 34824957 DOI: 10.9740/mhc.2021.11.320] [Reference Citation Analysis]
|
2 |
Findling RL, Atkinson S, Bachinsky M, Raiter Y, Abreu P, Ianos C, Chappell P. Efficacy, Safety, and Tolerability of Flexibly Dosed Ziprasidone in Children and Adolescents with Mania in Bipolar I Disorder: A Randomized Placebo-Controlled Replication Study. J Child Adolesc Psychopharmacol 2022. [PMID: 35394365 DOI: 10.1089/cap.2021.0121] [Reference Citation Analysis]
|
3 |
Turjeman S, Koren O. Using the microbiome in clinical practice. Microb Biotechnol 2022;15:129-34. [PMID: 34767683 DOI: 10.1111/1751-7915.13971] [Reference Citation Analysis]
|
4 |
Speyer H, Westergaard C, Albert N, Karlsen M, Stürup AE, Nordentoft M, Krogh J. Reversibility of Antipsychotic-Induced Weight Gain: A Systematic Review and Meta-Analysis. Front Endocrinol (Lausanne) 2021;12:577919. [PMID: 34393989 DOI: 10.3389/fendo.2021.577919] [Reference Citation Analysis]
|
5 |
Arranz MJ, Salazar J, Bote V, Artigas-baleri A, Serra-llovich A, Triviño E, Roige J, Lombardia C, Cancino M, Hernandez M, Cendros M, Duran-tauleria E, Maraver N, Hervas A. Pharmacogenetic Interventions Improve the Clinical Outcome of Treatment-Resistant Autistic Spectrum Disorder Sufferers. Pharmaceutics 2022;14:999. [DOI: 10.3390/pharmaceutics14050999] [Reference Citation Analysis]
|
6 |
Dash S, Syed YA, Khan MR. Understanding the Role of the Gut Microbiome in Brain Development and Its Association With Neurodevelopmental Psychiatric Disorders. Front Cell Dev Biol 2022;10:880544. [DOI: 10.3389/fcell.2022.880544] [Reference Citation Analysis]
|